Timothy M. Schmidt, MD, discusses the promise of bispecific antibodies in patients with multiple myeloma.
Timothy M. Schmidt, MD
Advertisement
Articles by Timothy M. Schmidt, MD
Timothy M. Schmidt, MD, discusses the safety and efficacy of teclistamab in patients with multiple myeloma.
Timothy M. Schmidt, MD, discusses the clinical implications of AMG 420 in multiple myeloma.
Timothy M. Schmidt, MD, discusses the utilization of bispecific antibodies in myeloma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
5